SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-22-027297
Filing Date
2022-05-17
Accepted
2022-05-16 18:22:36
Documents
90
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q/A f10q0921a1_allarityther.htm   iXBRL 10-Q/A 1078244
2 CERTIFICATION f10q0921a1ex31-1_allarity.htm EX-31.1 11751
3 CERTIFICATION f10q0921a1ex31-2_allarity.htm EX-31.2 12092
4 CERTIFICATION f10q0921a1ex32-1_allarity.htm EX-32.1 4394
5 CERTIFICATION f10q0921a1ex32-2_allarity.htm EX-32.2 4316
  Complete submission text file 0001213900-22-027297.txt   6761856

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE allr-20210930.xsd EX-101.SCH 85916
7 XBRL CALCULATION FILE allr-20210930_cal.xml EX-101.CAL 36463
8 XBRL DEFINITION FILE allr-20210930_def.xml EX-101.DEF 317821
9 XBRL LABEL FILE allr-20210930_lab.xml EX-101.LAB 635639
10 XBRL PRESENTATION FILE allr-20210930_pre.xml EX-101.PRE 335399
84 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921a1_allarityther_htm.xml XML 967709
Mailing Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139
Business Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-41160 | Film No.: 22931515
SIC: 2834 Pharmaceutical Preparations